Bosulif Approved for Pediatric Patients With Chronic Phase Ph+ CML
The FDA has approved bosulif (bosutinib) for patients aged 1 year or older with chronic phase Ph+ CML.
Chronic Myeloid Leukemia News
CHRONIC MYELOID LEUKEMIA ADVISOR
Chronic Myeloid Leukemia News
Risk of Albuminuria Higher With Dasatinib Than With Other TKIs
Patients with CML have a higher risk of albuminuria if they receive dasatinib rather than other TKIs, a study suggests.
Cancer Survivors With Functional Disabilities Have Higher Health Care Costs
Cancer survivors with functional disabilities have higher health care usage and medical costs than survivors without disabilities, data suggest.
Deaths Among Cancer Patients Increased During the First 2 Years of the COVID-19 Pandemic
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
Nilotinib Linked to Higher Risk of Diabetes, Hyperlipidemia in CML Patients
Chronic myeloid leukemia patients treated with nilotinib instead of other tyrosine kinase inhibitors may have a greater risk of developing diabetes and hyperlipidemia.
Systemic Therapies May Increase Risk of VTE in Patients With Cancer and COVID-19
Researchers found a higher risk of VTE in patients with cancer and COVID-19 who were receiving systemic cancer therapies.
Industry-Sponsored Cancer Trials More Likely to Have Consent Documents Translated
Industry-sponsored cancer trials are more likely to have consent documents translated to languages other than English, a study suggests.
Less Than Half of Cancer Trials Had Results Reported Within 1 Year of Completion
In an analysis of more than 10,000 cancer clinical trials, less than half had results reported within 1 year of trial completion.
Cancer Was Underdiagnosed in the First Year of the COVID-19 Pandemic
New research suggests that, in the United States, cancer was underdiagnosed during the first year of the COVID-19 pandemic.
Excessive Alcohol Consumption May Be Common in Cancer Patients, Survivors
Excessive alcohol consumption may be common among cancer survivors and cancer patients currently receiving treatment, a new study suggests.
Specialized Care Needed for LGBTQ+ AYAs With Cancer
LGBTQ+ adolescents and young adults with cancer face unique challenges in the health care setting, a review suggests.
Prognostic Factors Associated With Severe COVID-19 in Cancer Patients
Certain factors may increase the risk of severe COVID-19 in patients with cancer, research suggests.
How Food Insecurity Impacts Cancer Patients
As many as 55% of patients with cancer may be affected by food insecurity.
Short Bouts of Vigorous Physical Activity May Reduce Cancer Risk
Engaging in vigorous physical activity for 3 to 4 minutes per day is associated with a decrease in the risk of cancer among adults who typically don’t exercise, new research suggests.
How Housing Insecurity Impacts Cancer Patients
Housing insecurity can impede patients’ access to cancer screening, treatment, and survivorship care, increasing the risk of poor outcomes.
Failed Oncology Trials May Cost Up to $60 Billion Per Year
Researchers have estimated that failed oncology trials cost about $50 billion to $60 billion each year.
How Transportation Insecurity Impacts Cancer Patients
Cancer patients may be particularly susceptible to transportation-related disruptions in care.
Prior Authorization Requirements for Oral Cancer Drugs Have Increased Over Time
Prior authorization requirements for oral cancer drugs on Medicare part D formularies have increased in recent years, research suggests.
Lack of Sleep Linked to Increased Risk of Cancer
Getting less than 6 hours of sleep each night was associated with an increased risk of cancer in a large study.
Wastage of Oral Cancer Drugs Costs More Than $4000 per Patient, Study Suggests
Researchers studied 22 oral cancer drugs and found that wastage due to dose modifications or discontinuations resulted in a mean cost of $4290 per patient.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...